ADMA vs OGN · P/E 22, rev $238.9M vs P/E 3.4, rev $3.02B
ADMA Biologics Inc (ADMA) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ADMA and OGN stock pages for the full models.
Not investment advice.